PETS

PetMed Express, Inc.

1.65

USD

-0.05

-2.94%

Sep 11, 15:59 UTC -4

Closed

After-Market

1.67

+0.02

+1.45%

PetMed Express, Inc. Profile

About

PetMed Express, Inc. and subsidiaries, d/b/a 1-800-PetMeds (the `Company`), is a leading nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The Company offers consumers an attractive alternative for obtaining pet medications in terms of convenience, price, and speed of delivery. The Company markets its products through national advertising campaigns, which aim to increase the recognition of the `1-800-PetMeds` brand name, and `PetMeds` family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers, and maximize repeat purchases. The majority of the Company's sales are to residents in the United States. The Company's corporate headquarters and distribution facility are located in Delray Beach, Florida.

Info & Links

CEO

Leslie C.G. Campbell

Headquarters

420 SOUTH CONGRESS AVENUE
DELRAY BEACH, FL 33445, UNITED STATES

Auditor

Baker Tilly US, LLP

Share holders

130

Employees

189

PetMed Express, Inc. Statistics

Valuation Measures

Market Capitalization²

36.29M

Enterprise Value

23.21M

Enterprise Value/EBITDA(ttm)

-1.08

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.22

Price to Book(mrq)

1.59

Price to Cash(ytd)

5.53

Profitability

Gross Margin(ttm)

27.86%

Operating Margin(ttm)

-17.34%

Profit Margin(ttm)

-17.41%

Return on Equity(ttm)

-91.69%

Return on Invested Capital(ttm)

-92.75%

Return on Assets(ttm)

-35.15%

Income Statement

Revenue(ttm)

168.86M

Revenue Per Share(ttm)

7.79

Gross Profit(ttm)

47.15M

EBITDA(ttm)³

-21.52M

Net Income Available to Common(ttm)

-29.28M

Diluted EPS(ttm)

-1.38

Share Statistics

Beta (5Y Monthly)

0.78

52-Week Change

-39.56%

S&P 500 52-Week Change

18.73%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

21.68M

Dividend Yield

0.00%

Float⁴

21.40M

% Held by Insiders

1.30%

% Held by Institutions

73.33%

Balance Sheet

Total Cash(mrq)

13.08M

Total Cash Per Share(mrq)

0.60

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.68%

Quick Ratio(mrq)

0.47%

Book Value Per Share(mrq)

1.06

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.35

Free Cash Flow(ytd)

-8.33M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.